Pay in 4 interest-free payments of $12.60 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
whereas NHEJ inhibitor SCR7 has minimal effects
PubMed Central PMCID: PMC2976054
22(2):963-8
ATP-competitive inhibitor of Akt
LY2157299 - TGFβ Inhibitor. CAS# 700874-72-2 size:10mg solid whereas NHEJ inhibitor SCR7 hasLY2157299, CAS No. 700874 72 2, is a novel potent and selective TGF receptor type I and type II (TRI II) inhibitor with IC50 of 86 nM and 2 nM, respectively. LY2157299 could inhibit the TGF induced Smad2 phosphorylation in HUVEC cells, promote VEGF induced HUVEC cell migration, and show dose dependent potentiation of VEGF or bFGF induced cell proliferation. It can also inhibit TGFmediated Smad2 activation and hematopoietic suppression in primary
US$ 270.00
US$ 270.00
US$ 122.99
US$ 270.00
US$ 270.00
US$ 270.00
US$ 270.00
US$ 290.00
US$ 270.00
US$ 60.00